Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 15 studies | 35% ± 16% | |
endothelial cell | 14 studies | 35% ± 14% | |
glutamatergic neuron | 9 studies | 45% ± 23% | |
fibroblast | 6 studies | 23% ± 7% | |
cardiac muscle cell | 5 studies | 48% ± 12% | |
GABAergic neuron | 5 studies | 41% ± 11% | |
cholangiocyte | 4 studies | 39% ± 24% | |
adipocyte | 4 studies | 20% ± 5% | |
oligodendrocyte precursor cell | 4 studies | 30% ± 7% | |
epithelial cell | 3 studies | 42% ± 22% | |
glycinergic amacrine cell | 3 studies | 17% ± 2% | |
retina horizontal cell | 3 studies | 25% ± 7% | |
hepatocyte | 3 studies | 40% ± 21% | |
retinal pigment epithelial cell | 3 studies | 32% ± 20% | |
ciliated cell | 3 studies | 24% ± 7% | |
respiratory goblet cell | 3 studies | 40% ± 16% | |
smooth muscle cell | 3 studies | 19% ± 2% | |
basal cell | 3 studies | 31% ± 13% | |
interneuron | 3 studies | 55% ± 18% | |
mucus secreting cell | 3 studies | 30% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1852.15 | 964 / 966 | 99% | 12.38 | 522 / 527 |
stomach | 100% | 2387.52 | 358 / 359 | 98% | 13.93 | 279 / 286 |
esophagus | 100% | 3026.08 | 1440 / 1445 | 97% | 15.55 | 178 / 183 |
pancreas | 100% | 2625.27 | 328 / 328 | 97% | 10.96 | 172 / 178 |
prostate | 100% | 2579.20 | 244 / 245 | 95% | 5.76 | 479 / 502 |
bladder | 100% | 3170.10 | 21 / 21 | 92% | 10.38 | 463 / 504 |
skin | 100% | 2584.50 | 1808 / 1809 | 91% | 11.61 | 428 / 472 |
kidney | 99% | 2204.87 | 88 / 89 | 86% | 7.04 | 774 / 901 |
uterus | 100% | 1757.23 | 170 / 170 | 80% | 5.36 | 366 / 459 |
brain | 97% | 1989.90 | 2574 / 2642 | 76% | 3.78 | 536 / 705 |
lung | 89% | 1049.69 | 514 / 578 | 83% | 6.64 | 964 / 1155 |
breast | 94% | 1327.35 | 432 / 459 | 68% | 4.35 | 764 / 1118 |
liver | 93% | 1549.81 | 211 / 226 | 64% | 4.75 | 260 / 406 |
adrenal gland | 99% | 1501.21 | 255 / 258 | 54% | 3.82 | 125 / 230 |
ovary | 56% | 419.62 | 101 / 180 | 82% | 8.46 | 352 / 430 |
thymus | 99% | 1477.08 | 644 / 653 | 28% | 0.91 | 172 / 605 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.15 | 1 / 1 |
heart | 97% | 2233.22 | 834 / 861 | 0% | 0 | 0 / 0 |
adipose | 95% | 1062.08 | 1146 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 93% | 1460.66 | 1243 / 1335 | 0% | 0 | 0 / 0 |
muscle | 92% | 1547.72 | 735 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 5.15 | 71 / 80 |
spleen | 87% | 790.51 | 209 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 4.24 | 33 / 45 |
peripheral blood | 0% | 2.97 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045739 | Biological process | positive regulation of DNA repair |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006974 | Biological process | DNA damage response |
GO_2000987 | Biological process | positive regulation of behavioral fear response |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0051775 | Biological process | response to redox state |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0007417 | Biological process | central nervous system development |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_1990513 | Cellular component | CLOCK-BMAL transcription complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NPAS2 |
Protein name | Neuronal PAS domain protein 2 NPAS2 protein Neuronal PAS domain-containing protein 2 (Neuronal PAS2) (Basic-helix-loop-helix-PAS protein MOP4) (Class E basic helix-loop-helix protein 9) (bHLHe9) (Member of PAS protein 4) (PAS domain-containing protein 4) Neuronal PAS domain protein 2 isoform A (Neuronal PAS domain protein 2, isoform CRA_e) |
Synonyms | PASD4 hCG_27614 BHLHE9 MOP4 |
Description | FUNCTION: Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. The NPAS2-BMAL1 heterodimer positively regulates the expression of MAOA, F7 and LDHA and modulates the circadian rhythm of daytime contrast sensitivity by regulating the rhythmic expression of adenylate cyclase type 1 (ADCY1) in the retina. NPAS2 plays an important role in sleep homeostasis and in maintaining circadian behaviors in normal light/dark and feeding conditions and in the effective synchronization of feeding behavior with scheduled food availability. Regulates the gene transcription of key metabolic pathways in the liver and is involved in DNA damage response by regulating several cell cycle and DNA repair genes. Controls the circadian rhythm of NR0B2 expression by binding rhythmically to its promoter (By similarity). Mediates the diurnal variation in the expression of GABARA1 receptor in the brain and contributes to the regulation of anxiety-like behaviors and GABAergic neurotransmission in the ventral striatum (By similarity). . |
Accessions | H7C080 ENST00000451740.1 ENST00000335681.10 A2I2P5 H7C0Z2 ENST00000433408.1 Q99743 H7C0J4 H7BZA3 X5DR62 H7BZY5 A0PJF9 ENST00000427413.5 ENST00000448812.5 ENST00000450763.1 |